Swerdel, Joel

Semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy

Cai, C. X., Hribar, M., Baxter, S., Goetz, K., Swaminathan, S. S., Flowers, A., Brown, E. N., Toy, B., Xu, B., Chen, J., et al. (2025) · JAMA Ophthalmology

Diabetes Treatment and ManagementDrug-Induced Ocular Toxicity

Cited by 129

Health-Analytics Data to Evidence Suite (HADES): open-source software for observational research.

Schuemie, M., Reps, J., Black, A., Defalco, F., Evans, L., Fridgeirsson, E., Gilbert, J. P., Knoll, C., Lavallee, M., Rao, G. A., et al. (2024) · Studies in Health Technology and Informatics

Machine Learning in HealthcareMedical Coding and Health Information

Cited by 28

Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab

Cai, C. X., Nishimura, A., Bowring, M. G., Westlund, E., Tran, D., Ng, J. H., Nagy, P., Cook, M., McLeggon, J.-A., DuVall, S. L., et al. (2024) · Ophthalmology Retina

Retinal Diseases and TreatmentsDrug-Induced Ocular Toxicity

Cited by 20

PheValuator 2.0: methodological improvements for the PheValuator approach to semi-automated phenotype algorithm evaluation.

Swerdel, J. N., Schuemie, M., Murray, G., & Ryan, P. B. (2022) · Journal of Biomedical Informatics

Machine Learning in HealthcareMedical Coding and Health Information

Cited by 20